Bryn Mawr Trust CO Teva Pharmaceutical Industries LTD Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bryn Mawr Trust CO holds 28,850 shares of TEVA stock, worth $470,832. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,850
Previous 2,759
945.67%
Holding current value
$470,832
Previous $49,000
1195.92%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
678Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$702 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$636 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$598 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$463 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$444 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.1B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...